University at Buffalo - The State University of New York
Skip to Content
UBMD Physicians' Group

Clinical Trials

International Guillain Barre Syndrome Outcome Study (IGOS)

Investigation into the clinical course and outcome of patients with GBS, identifying clinical and biological predictors of outcome as early as possible after onset of the neuropathy.

To determine predictors of ultimate outcome in patients with Guillain Barre Syndrome (GBS).

Eligibility

Children (with adult consent) and adults are both eligible.

Requirements

Patients with GBS or GBS variants including Miller Fisher Syndrome, identified within two weeks of onset of their weakness

Reimbursement

None

Investigator

Nicholas J. Silvestri, MD; Gil I. Wolfe, MD

Contact Information

Name: Kara Patrick
Phone: 716-859-4125
Email: kpatrick@buffalo.edu